oracine has been researched along with Burkitt Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Rubeai, M; Klucar, J | 1 |
1 other study(ies) available for oracine and Burkitt Lymphoma
| Article | Year |
|---|---|
G2 cell cycle arrest and apoptosis are induced in Burkitt's lymphoma cells by the anticancer agent oracin.
Topics: Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; Ethanolamines; G2 Phase; Genes, bcl-2; Isoquinolines; Mitosis; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 1997 |